Previous studies using mRNA-based type I IFN scores have consistently found a higher frequency of SSA/SSB antibody positivity, hypergammaglobulinemia and lymphopenia in IFN score positive patients (9–11, 24). This evidence concerns the gene IFNA1 and lymphopenia.